Ceramide Induces Human Hepcidin Gene Transcription through JAK/STAT3 Pathway

Authors

Sizhao Lu, University of Nebraska Medical Center
Sathish Kumar Natarajan, University of Nebraska - LincolnFollow
Justin L. Mott, University of Nebraska Medical Center
Kusum K. Kharbanda, University of Nebraska Medical CenterFollow
Duygu Dee Harrison-Findik, University of Nebraska Medical Center

Document Type

Article

Date of this Version

2016

Citation

Lu S, Natarajan SK, Mott JL, Kharbanda KK, Harrison-Findik DD (2016) Ceramide Induces Human Hepcidin Gene Transcription through JAK/ STAT3 Pathway. PLoS ONE 11(1): e0147474.

Comments

Copyright © 2016 Lu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License

Abstract

Changes in lipid metabolism and iron content are observed in the livers of patients with fatty liver disease. The expression of hepcidin, an iron-regulatory and acute phase protein synthesized by the liver, is also modulated. The potential interaction of lipid and iron metabolism is largely unknown.We investigated the role of lipid intermediate, ceramide in the regulation of human hepcidin gene, HAMP. Human hepatoma HepG2 cells were treated with cell-permeable ceramide analogs. Ceramide induced significant up-regulation of HAMP mRNA expression in HepG2 cells. The effect of ceramide on HAMP expression was mediated through transcriptional mechanisms because it was completely blocked with actinomycin D treatment. Reporter assays also confirmed the activation of 0.6 kb HAMP promoter by ceramide. HepG2 cells treated with ceramide displayed increased phosphorylation of STAT3, JNK, and NF-κB proteins. However, ceramide induced the binding of STAT3, but not NF-κB or c-Jun, to HAMP promoter, as shown by the chromatin immunoprecipitation assays. The mutation of STAT3 response element within 0.6 kb HAMP promoter region significantly inhibited the stimulatory effect of ceramide on HAMP promoter activity. Similarly, the inhibition of STAT3 with a pan-JAK kinase inhibitor and STAT3 siRNA pool also diminished the induction of both HAMP promoter activity and mRNA expression by ceramide. In conclusion, we have shown a direct role for ceramide in the activation of hepatic HAMP transcription via STAT3. Our findings suggest a crosstalk between lipid and iron metabolism in the liver, which may contribute to the pathogenesis of obesity-related fatty liver disease.